logo
Select company
Select metric
-37.45%Buyback Yield
VS
Market
7
Sector
19
Industry
24
History
24
$ 1.7Close
$ 1.15 - $ 5.82 52-Week Range
Ticker Information

Ticker

HUMA

Company Name

HUMACYTE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HUMACYTE INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HUMA - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-37.45%$ 276.36M$ 103.51M
3/31/2025-37.66%$ 268.36M$ 101.05M
12/31/2024-36.68%$ 264.48M$ 97.02M
9/30/2024-6.27%$ 727.47M$ 45.6M
6/30/2024-5.57%$ 793.68M$ 44.19M
3/31/2024-6.72%$ 652.58M$ 43.84M
12/31/2023-0.15%$ 370.35M$ 566K
9/30/2023-0.27%$ 228.9M$ 619K
6/30/2023-0.18%$ 417.88M$ 737K
3/31/2023-0.16%$ 410.22M$ 653K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HUMACYTE INC's latest trailing twelve months (TTM) Buyback Yield stands at 0%.
  • Over the past 5 years, HUMACYTE INC's average Buyback Yield has been -19.43%.
  • The median Buyback Yield for HUMACYTE INC during this period was -6.49%
  • HUMACYTE INC reached its highest Buyback Yield over the past 5 years at -0.03%.
  • The lowest Buyback Yield recorded by HUMACYTE INC in the same timeframe -75.54%

HUMACYTE INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
RNAC : CARTESIAN THERAPEUTICS INC -45.83%MREO : MEREO BIOPHARMA GROUP PLC 0.13%CRDF : CARDIFF ONCOLOGY INC -23.44%NWBO : NORTHWEST BIOTHERAPEUTICS INC -6.78%BTAI : BIOXCEL THERAPEUTICS INC -20.83%ABEO : ABEONA THERAPEUTICS INC -6.01%VTGN : VISTAGEN THERAPEUTICS INC -4.39%INBX : INHIBRX BIOSCIENCES INC 0%SEPN : SEPTERNA INC -59.19%ICU : SEASTAR MEDICAL HOLDING CORP -89.21%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for HUMACYTE INC is calculated as follows: (-1 * CF - Equity [ $ 0 ]) / Market Cap [ $ 127.26M ]
(=) Buyback Yield [ 0% ]

HUMA - Buyback Yield, Last 5 years

-75.54%

Minimum

Dec 31, 2020

-0.03%

Maximum

Jun 30, 2021

-19.43%

Average

-6.49%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.7%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.43%
average0.64%
median0.01%
std2.7%